Software Will Solve Broken Systems in Every Aspect of Healthcare

Scott Barclay, Managing Director at Insight Partners, delves into the potential of software to revolutionize healthcare's flawed systems. He explores the dynamics of VC firms operating across various stages in the ecosystem, weighing the pros and cons of seed-stage investments for larger firms. Additionally, Scott shares insights on why now is an opportune time to embark on AI endeavors.In this episode, you’ll learn:[3:47] What approaches is Insight Partners employing to establish the most scalable framework as a leading global software investor?[7:32] A VC's reputation is built on their interactions with founders, regardless of whether or not they get on the founder’s cap table.[11:29] Genuine success narratives within healthcare emerge at the crossroads of empathetic product development and high-quality go-to-market strategies.[16:10] 2023 to 2025 will be a phenomenal time to start something in AI.[24:56] Certain occasions demand the recognition that achieving greatness requires strategic boldness and the willingness to take early leaps.The non-profit organization that Scott is passionate about: Camp JabberwockyAbout Scott BarclayScott Barclay is a managing director for the health practice at Insight Partners. He’s focused on how teams—armed with technical prowess and an earned empathy to the problem—can build something greater than themselves in healthcare with software and data. Previously, Scott was a partner at DCVC, an angel investor, and an operator at Surescripts. He has been instrumental in Insight’s investment in UnoBravo, Kintsugi, Trialjectory, IDOVEN, AiVF among others.About Insight PartnersInsight Partners is a New York-based global software investor that partners with growth-stage technology and software companies, with a deep focus in Fintech, Cybersecurity, AI/ML, DevOps, and Healthcare sectors. Insight’s portfolio companies include wiz, Calm, Checkout, Divvy, Kaseya, Espressive, ncino, onetrust, Pluralsight, among others.Subscribe to our podcast and stay tuned for our next episode. Follow Us:  Twitter | Linkedin | Instagram | Facebook